Ghrelin and lipid metabolism: Key partners in energy balance

Journal of Molecular Endocrinology

Volumn 46, Issue 2, 2011, Pages 43-63

  Varela, Luis ^a,b   Vázquez, María J ^a,b   Cordido, Fernando ^c,d   Nogueiras, Rubén ^a,b   Vidal Puig, Antonio ^e   Diéguez, Carlos ^a,b   López, Miguel ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF A CORUÑA   (Spain)

^d Hospital A Coruna   (Spain)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; GHRELIN; GHRELIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NEUROPEPTIDE; TRANSCRIPTION FACTOR BSX; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ARCUATE NUCLEUS; ENERGY BALANCE; ENZYME REGULATION; FATTY ACID METABOLISM; HUMAN; HYPOTHALAMUS; LIPID METABOLISM; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BODY WEIGHT; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; GHRELIN; GROWTH HORMONE; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MICE; MICE, TRANSGENIC; OBESITY; RECEPTORS, GHRELIN; RODENTIA; SIGNAL TRANSDUCTION;

EID: 79953714548     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-10-0068     Document Type: Review

References (224)

1. Ahima RS 2000 Leptin and the neuroendocrinology offasting. Frontiers of Hormone Research 26 42-56. (doi:10.1159/000061014)
2. Ahima RS & Flier JS 2000 Leptin. Annual Review of Physiology 62 413-437. (doi:10.1146/annurev.physiol.62.1.413)
3. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382 250-252. (doi:10.1038/382250a0)
4. Alquier T, Kawashima J, Tsuji Y & Kahn BB 2007 Role of hypothalamic adenosine 5′-monophosphate-activated protein kinase in the impaired counterregulatory response induced by repetitive neu-roglucopenia. Endocrinology 148 1367-1375. (doi:10.1210/en. 2006-1039)
5. Ambati S, Duan J, Duff E, Choi YH, Hartzell DL, Della-Fera MA & Baile CA 2007 Gene expression in arcuate nucleus-median eminence of rats treated with leptin or ciliary neurotrophic factor. Biofactors 31 133-144. (doi:10.1002/biof.5520310204)
6. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE & Means AR 2008 Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metabolism 7 377-388. (doi:10.1016/j.cmet.2008.02.011)
7. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D & Small CJ 2004 AMP-activated protein kinase plays a role in the control of food intake. Journal of Biological Chemistry 279 12005-12008. (doi:10.1074/jbc.C300557200)
8. Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschop MH, Shanabrough M, Cline G, Shulman GI et al. 2008 UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454 846-851. (doi:10.1038/nature07181)
9. Andrews ZB, Erion DM, Beiler R, Choi CS, Shulman GI & Horvath TL 2010 Uncoupling protein-2 decreases the lipogenic actions of ghrelin. Endocrinology 151 2078-2086. (doi:10.1210/en.2009-0850)
10. Arvaniti K, Huang Q & Richard D 2001 Effects of leptin and corticosterone on the expression of corticotropin-releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse. Neuroendocrinology 73 227-236. (doi:10. 1159/000054639)
11. Belgardt BF, Husch A, Rother E, Ernst MB, Wunderlich FT, Hampel B, Klockener T, Alessi D, Kloppenburg P & Bruning JC 2008 PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and-independent pathways in control of energy homeostasis and stress response. Cell Metabolism 7 291-301. (doi:10.1016/j.cmet. 2008.01.006)
12. Bennett PA, Thomas GB, Howard AD, Feighner SD, Van Der Ploeg LH, Smith RG & Robinson IC 1997 Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology 138 4552-4557. (doi:10.1210/en. 138.11.4552)
13. Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ & Woods SC 2002 The catabolic action of insulin in the brain is mediated by melanocortins. Journal of Neuroscience 22 9048-9052.
14. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W & Sawchenko PE 1992 The melanin-concentrating hormone system of the rat brain: an immuno-and hybridization histochemical characterization. Journal of Comparative Neurology 319 218-245. (doi:10.1002/cne.903190204)
15. Briski KP & Parihar M 2008 Effects of orchidectomy on adaptation of arcuate neuropeptide Y, proopiomelanocortin, and cocaine-and amphetamine-related transcript gene profiles to recurring insulin-induced hypoglycemia in the male rat. Neuropeptides 42 585-591. (doi:10.1016/j.npep.2008.09.001)
16. Broberger C, de Lecea L, Sutcliffe JG & Hokfelt T 1998 Hypocretin/ orexin-and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. Journal of Comparative Neurology 402 460-474. (doi:10.1002/ (SICI)1096-9861(19981228)402:4<460::AID-CNE3>3.0.CO;2-S)
17. Buettner C, Pocai A, Muse ED, Etgen AM, Myers MG Jr & Rossetti L 2006 Critical role of STAT3 in leptin's metabolic actions. Cell Metabolism 4 49-60. (doi:10.1016/j.cmet.2006.04.014)
18. Buettner C, Muse ED, Cheng A, Chen L, Scherer T, Pocai A, Su K, Cheng B, Li X, Harvey-White J et al. 2008 Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nature Medicine 14 667-675. (doi:10.1038/nm1775)
19. Carling D, Sanders MJ & Woods A 2008 The regulation of AMP-activated protein kinase by upstream kinases. International Journal of Obesity 32 (Supplement 4) S55-S59. (doi:10.1038/ijo. 2008.124)
20. Cesquini M, Stoppa GR, Prada PO, Torsoni AS, Romanatto T, Souza A, Saad MJ, Velloso LA & Torsoni MA 2008 Citrate diminishes hypothalamic acetyl-CoA carboxylase phosphorylation and modulates satiety signals and hepatic mechanisms involved in glucose homeostasis in rats. Life Sciences 82 1262-1271. (doi:10. 1016/j.lfs.2008.04.015)
21. Cha SH & Lane MD 2009 Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway. Biochemical and Biophysical Research Communications 386 212-216. (doi:10.1016/j.bbrc.2009.06.017)
22. Cha SH, Wolfgang M, Tokutake Y, Chohnan S & Lane MD 2008 Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. PNAS 105 16871-16875. (doi:10. 1073/pnas.0809255105)
23. Chakravarthy MV, Zhu Y, López M, Yin L, Wozniak DW, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD et al. 2007 Brain fatty acid synthase activates PPAR-α to maintain energy homeostasis. Journal of Clinical Investigation 117 2539-2552. (doi:10.1172/JCI31183)
24. Chang GQ, Karatayev O, Davydova Z, Wortley K & Leibowitz SF 2005 Glucose injection reduces neuropeptide Y and agouti-related protein expression in the arcuate nucleus: a possible physiological role in eating behavior. Brain Research. Molecular Brain Research 135 69-80. (doi:10.1016/j.molbrainres.2004.12.017)
25. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM et al. 2004 Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP). Endocrinology 145 2607-2612. (doi:10.1210/en.2003-1596)
26. Coll AP, Challis BG, López M, Piper S, Yeo GS & O'Rahilly S 2005 Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids. Diabetes 54 2269-2276. (doi:10.2337/diabetes.54.8.2269)
27. Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, Fernandez MR, Fisher K, Kortum RL, Hong EG et al. 2009 KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metabolism 10 366-378. (doi:10.1016/ j.cmet.2009.09.010)
28. Cota D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer D, Yassouridis A, Thone-Reineke C, Ortmann S et al. 2003 The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. Journal of Clinical Investigation 112 423-431. (doi:10.1172/JCI200317725)
29. Cotero VE & Routh VH 2009 Insulin blunts the response of glucose-excited neurons in the ventrolateral-ventromedial hypothalamic nucleus to decreased glucose. American Journal of Physiology. Endocrinology and Metabolism 296 E1101-E1109. (doi:10.1152/ ajpendo.90932.2008)
30. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, Strasburger CJ, Bidlingmaier M, Esterman M, Heiman ML et al. 2003 The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37 649-661. (doi:10.1016/S0896-6273(03)00063-1)
31. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE & Weigle DS 2001 A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 1714-1719. (doi:10.2337/ diabetes.50.8.1714)
32. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A & Weigle DS 2002 Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine 8 643-644. (doi:10.1038/nm0702-643)
33. Dai Y, Wolfgang MJ, Cha SH & Lane MD 2007 Localization and effect of ectopic expression of CPT1c in CNS feeding centers. Biochemical and Biophysical Research Communications 359 469-474. (doi:10.1016/ j.bbrc.2007.05.161)
34. Dowell P, Hu Z & Lane MD 2005 Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annual Review of Biochemistry 74 515-534. (doi:10.1146/annurev.biochem. 73.011303.074027)
35. Drazen DL, Vahl TP, D'Alessio DA, Seeley RJ & Woods SC 2006 Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology 147 23-30. (doi:10.1210/en.2005-0973)
36. Dryden S, Pickavance L, Henderson L & Williams G 1998 Hyperphagia induced by hypoglycemia in rats is independent of leptin and hypothalamic neuropeptide Y (NPY). Peptides 19 1549-1555. (doi:10.1016/S0196-9781(98)00106-5)
37. Dunbar J, Lapanowski K, Barnes M & Rafols J 2005 Hypothalamic agouti-related protein immunoreactivity in food-restricted, obese, and insulin-treated animals: evidence for glia cell localization. Experimental Neurology 191 184-192. (doi:10.1016/j.expneurol.2004. 09.002)
38. Egecioglu E, Bjursell M, Ljungberg A, Dickson SL, Kopchick JJ, Bergstrom G, Svensson L, Oscarsson J, Tornell J & Bohlooly Y 2006 Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. American Journal of Physiology. Endocrinology and Metabolism 290 E317-E325. (doi:10.1152/ajpendo.00181.2005)
39. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS et al. 1998 Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. Journal of Comparative Neurology 402 442-459. (doi:10.1002/(SICI)1096-9861(19981228)402:4 < 442:: AID-CNE2O3.0.CO;2-R)
40. Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB & Elmquist JK 1999 Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23 775-786. (doi:10.1016/S0896-6273(01)80035-0)
41. Ernst MB, Wunderlich CM, Hess S, Paehler M, Mesaros A, Koralov SB, Kleinridders A, Husch A, Munzberg H, Hampel B et al. 2009 Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. Journal of Neuroscience 29 11582-11593. (doi:10.1523/JNEUROSCI. 5712-08.2009)
42. Fan W, Boston BA, Kesterson RA, Hruby VJ & Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 165-168. (doi:10.1038/385165a0)
43. Fan X, Ding Y, Brown S, Zhou L, Shaw M, Vella MC, Cheng H, McNay EC, Sherwin RS & McCrimmon RJ 2009 Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counter-regulatory responses to hypoglycemia in a rodent model of type 1 diabetes. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 296 R1702-R1708. (doi:10.1152/ajpregu. 90600.2008)
44. Fekete C, Singru PS, Sanchez E, Sarkar S, Christoffolete MA, Riberio RS, Rand WM, Emerson CH, Bianco AC & Lechan RM 2006 Differential effects of central leptin, insulin, or glucose administration during fasting on the hypothalamic-pituitary-thyroid axis and feeding-related neurons in the arcuate nucleus. Endocrinology 147 520-529. (doi:10.1210/en.2005-0956)
45. Foster-Schubert KE & Cummings DE 2006 Emerging therapeutic strategies for obesity. Endocrine Reviews 27 779-793. (doi:10.1210/er. 2006-0041)
46. Gamber KM, Macarthur H & Westfall TC 2005 Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 49 646-652. (doi:10.1016/j.neuropharm.2005. 04.017)
47. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL et al. 2007 Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. PNAS 104 17358-17363. (doi:10.1073/pnas.0708385104)
48. Garcia A, Alvarez CV, Smith RG & Dieguez C 2001 Regulation of pit-1 expression by ghrelin and ghrp-6 through the GH secretagogue receptor. Molecular Endocrinology 15 1484-1495. (doi:10.1210/me. 15.9.1484)
49. Germano CM, de Castro M, Rorato R, Laguna MT, Antunes-Rodrigues J, Elias CF & Elias LL 2007 Time course effects of adrenalectomy and food intake on cocaine-and amphetamine-regulated transcript expression in the hypothalamus. Brain Research 1166 55-64. (doi:10. 1016/j.brainres.2007.05.077)
50. Gonzalez CR, Vazquez MJ, Lopez M & Dieguez C 2008 Influence of chronic undernutrition and leptin on GOAT mRNA levels in rat stomach mucosa. Journal of Molecular Endocrinology 41 415-421. (doi:10.1677/JME-08-0102)
51. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, Smith RG, Van Der Ploeg LH & Howard AD 1997 Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Research. Molecular Brain Research 48 23-29. (doi:10.1016/S0169-328X(97)00071-5)
52. Guillod-Maximin E, Roy AF, Vacher CM, Aubourg A, Bailleux V, Lorsignol A, Penicaud L, Parquet M & Taouis M 2009 Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons,. Journal of Endocrinology 200 93-105. (doi:10.1677/JOE-08-0348)
53. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE & Hale JE 2008 Ghrelin octanoylation mediated by an orphan lipid transferase. PNAS 105 6320-6325. (doi:10.1073/pnas.0800708105)
54. Hagan MM, Rushing PA, Pritchard LM, Schwartz MW, Strack AM, Van Der Ploeg LH, Woods SC & Seeley RJ 2000 Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 279 R47-R52.
55. Hahn TM, Breininger JF, Baskin DG & Schwartz MW 1998 Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neuroscience 1 271-272. (doi:10.1038/1082)
56. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK & Friedman JM 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 543-546. (doi:10.1126/science.7624777)
57. Han SM, Namkoong C, Jang PG, Park IS, Hong SW, Katakami H, Chun S, Kim SW, Park JY, Lee KU et al. 2005 Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypogly-caemia in rats. Diabetologia 48 2170-2178. (doi:10.1007/s00125-005-1913-1)
58. Haskell-Luevano C & Monck EK 2001 Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor. Regulatory Peptides 99 1-7. (doi:10.1016/S0167-0115(01) 00234-8)
59. Haskell-Luevano C, Cone RD, Monck EK & Wan YP 2001 Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40 6164-6179. (doi:10.1021/bi010025q)
60. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG & Hardie DG 2005 Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metabolism 2 9-19. (doi:10.1016/j. cmet.2005.05.009)
61. He W, Lam TK, Obici S & Rossetti L 2006 Molecular disruption of hypothalamic nutrient sensing induces obesity. Nature Neuroscience 9 227-233. (doi:10.1038/nn1626)
62. Hentges ST, Low MJ & Williams JT 2005 Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids. Journal of Neuroscience 25 9746-9751. (doi:10.1523/JNEUROSCI.2769-05.2005)
63. Hidaka S, Yoshimatsu H, Kondou S, Oka K, Tsuruta Y, Sakino H, Itateyama E, Noguchi H, Himeno K, Okamoto K et al. 2001 Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats. Journal of Neurochemistry 77 993-1000. (doi:10.1046/j.1471-4159.2001.00317.x)
64. Holst B, Cygankiewicz A, Halkjar JT, Ankersen M & Schwartz TW 2003 High constitutive signaling of the ghrelin receptor-identification of a potent inverse agonist. Molecular Endocrinology 17 2201-2210. (doi:10.1210/me.2003-0069)
65. Horvath TL, Diano S & van den Pol AN 1999 Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. Journal of Neuroscience 19 1072-1087.
66. Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, Yoshii M & Ozawa K 2008 Endoplasmic reticulum stress induces leptin resistance. Molecular Pharmacology 74 1610-1619. (doi:10.1124/mol. 108.050070)
67. Hu Z, Cha SH, Chohnan S & Lane MD 2003 Hypothalamic malonyl-CoA as a mediator of feeding behavior. PNAS 100 12624-12629. (doi:10.1073/pnas.1834402100)
68. Hu Z, Cha SH, van Haasteren G, Wang J & Lane MD 2005 Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. PNAS 102 3972-3977. (doi:10.1073/pnas.0500619102)
69. Ikeda H, West DB, Pustek JJ, Figlewicz DP, Greenwood MR, Porte D Jr & Woods SC 1986 Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 7 381-386.
70. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB & Wheeler MB 2002 Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51 3211-3219.
71. Kahn BB, Alquier T, Carling D & Hardie DG 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metabolism 1 15-25. (doi:10. 1016/j.cmet.2004.12.003)
72. Kalra SP, Dube MG, Sahu A, Phelps CP & Kalra PS 1991 Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. PNAS 88 10931-10935. (doi:10. 1073/pnas.88.23.10931)
73. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H & Wakabayashi I 2000 Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141 4797-4800. (doi:10.1210/en.141.12.4797)
74. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H & Wakabayashi I 2001 Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and agouti-related protein mRNA levels and body weight in rats. Diabetes 50 2438-2443. (doi:10.2337/diabetes.50.11. 2438)
75. Kim EM, Grace MK, Welch CC, Billington CJ & Levine AS 1999 STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. American Journal of Physiology 276 R1320-R1326.
76. Kim EK, Miller I, Landree LE, Borisy-Rudin FF, Brown P, Tihan T, Townsend CA, Witters LA, Moran TH, Kuhajda FP et al. 2002 Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment. American Journal of Physiology. Endocrinology and Metabolism 283 E867-E879.
77. Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS et al. 2004 Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nature Medicine 10 727-733. (doi:10.1038/nm1061)
78. Kim MS, Pak YK, Jang PG, Namkoong C, Choi YS, Won JC, Kim KS, Kim SW, Kim HS, Park JY et al. 2006 Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nature Neuroscience 9 901-906. (doi:10.1038/nn1731)
79. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, Schurmann A, Joost HG, Jandacek RJ, Hale JE et al. 2009 GOAT links dietary lipids with the endocrine control of energy balance. Nature Medicine 15 741-745. (doi:10.1038/nm.1997)
80. Kitamura T, Feng Y, Ido KY, Chua SC, Xu AW, Barsh GS, Rossetti L & Accili D 2006 Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nature Medicine 12 534-540. (doi:10. 1038/nm1392)
81. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F & Bruning JC 2008 Central insulin action regulates peripheral glucose and fat metabolism in mice. Journal of Clinical Investigation 118 2132-2147. (doi:10.1172/ JCI31073)
82. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H & Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 656-660. (doi:10.1038/45230)
83. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB et al. 2005 Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. Journal of Biological Chemistry 280 25196-25201. (doi:10.1074/jbc. C500175200)
84. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-White J, Liposits Z, Kunos G, Grossman AB et al. 2008 The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3 e1797. (doi:10. 1371/journal.pone.0001797)
85. Konner AC, Janoschek R, Plum L, Jordan SD, Rother E, Ma X, Xu C, Enriori P, Hampel B, Barsh GS et al. 2007 Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production. Cell Metabolism 5 438-449. (doi:10.1016/j.cmet. 2007.05.004)
86. Korner J, Wissig S, Kim A, Conwell IM & Wardlaw SL 2003 Effects of agouti-related protein on metabolism and hypothalamic neuropeptide gene expression. Journal of Neuroendocrinology 15 1116-1121. (doi:10.1111/j.1365-2826.2003.01113.x)
87. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N et al. 1998 Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 72-76. (doi:10.1038/29993)
88. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, Kozono H, Takamoto I, Okamoto S, Shiuchi T et al. 2007 Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metabolism 6 55-68. (doi:10.1016/j.cmet. 2007.06.003)
89. Lage R, Diéguez C, Vidal-Puig A & López M 2008 AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends in Molecular Medicine 14 539-549. (doi:10.1016/j.molmed. 2008.09.007)
90. Lage R, Vázquez MJ, Varela L, Saha AK, Vidal-Puig A, Nogueiras R, Diéguez C & López M 2010 Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB Journal 24 2670-2679. (doi:10.1096/fj.09-150672)
91. Lane MD & Cha SH 2009 Effect of glucose and fructose on food intake via malonyl-CoA signaling in the brain. Biochemical and Biophysical Research Communications 382 1-5. (doi:10.1016/j.bbrc. 2009.02.145)
92. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS et al. 1998 The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. PNAS 95 322-327. (doi:10.1073/pnas.95.1.322)
93. Lee K, Li B, Xi X, Suh Y & Martin RJ 2005 Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 146 3-10. (doi:10.1210/en.2004-0968)
94. Lee GH, Kim HK, Chae SW, Kim DS, Ha KC, Cuddy M, Kress C, Reed JC, Kim HR & Chae HJ 2007 Bax inhibitor-1 regulates endoplasmic reticulum stress-associated reactive oxygen species and heme oxygenase-1 expression. Journal of Biological Chemistry 282 21618-21628. (doi:10.1074/jbc.M700053200)
95. van der Lely AJ 2009 Ghrelin and new metabolic frontiers. Hormone Research 71 (Supplement 1) 129-133. (doi:10.1159/000178055)
96. van der Lely AJ, Tschop M, Heiman ML & Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocrine Reviews 25 426-457. (doi:10.1210/er.2002-0029)
97. Li HY, Hwang HW & Hu YH 2002 Functional characterizations of cocaine-and amphetamine-regulated transcript mRNA expression in rat hypothalamus. Neuroscience Letters 323 203-206. (doi:10.1016/ S0304-3940(02)00151-9)
98. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD & Kuhajda FP 2000 Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288 2379-2381. (doi:10.1126/science.288.5475.2379)
99. López M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vázquez MJ, Finer N, Powles T et al. 2006 Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55 1327-1336. (doi:10.2337/db05-1356)
100. López M, Lelliott CJ & Vidal-Puig A 2007 Hypothalamic fatty acid metabolism: a housekeeping pathway that regulates food intake. BioEssays 29 248-261. (doi:10.1002/bies.20539)
101. López M, Lage R, Saha AK, Pérez-Tilve D, Vázquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodríguez-Cuenca S et al. 2008a Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metabolism 7 389-399. (doi:10.1016/j.cmet. 2008.03.006)
102. López M, Saha AK, Diéguez C & Vidal-Puig A 2008b The AMPK-malonyl-CoA-CPT1 axis in the control of hypothalamic neuronal function-reply. Cell Metabolism 8 176. (doi:10.1016/ j.cmet.2008.08.003)
103. López M, Varela L, Vázquez MJ, Rodríguez-Cuenca S, González CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R et al. 2010 Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nature Medicine 16 1001-1008. (doi:10.1038/nm.2207)
104. Maccario M, Grottoli S, Procopio M, Oleandri SE, Rossetto R, Gauna C, Arvat E & Ghigo E 2000 The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factors. International Journal of Obesity and Related Metabolic Disorders 24 (Supplement 2) S96-S99.
105. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Burn P & Palmiter RD 1999 Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nature Genetics 21 119-122. (doi:10.1038/5070)
106. Martínez de Morentin PB, González CR & López M 2010a AMP-activated protein kinase: 'a cup of tea' against cholesterol-induced neurotoxicity. Journal of Pathology 222 329-334. (doi:10.1002/path.2778)
107. Martínez de Morentin PB, Varela L, Ferno J, Nogueiras R, Diéguez C & López M 2010b Hypothalamic lipotoxicity and the metabolic syndrome. Biochimica et Biophysica Acta 1801 350-361. (doi:10.1016/ j.bbalip.2009.09.016)
108. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, Hosoda H, Kojima M & Kangawa K 2000 Ghrelin stimulates gastric acid secretion and motility in rats. Biochemical and Biophysical Research Communications 276 905-908. (doi:10.1006/bbrc.2000.3568)
109. McCrimmon RJ, Fan X, Ding Y, Zhu W, Jacob RJ & Sherwin RS 2004 Potential role for AMP-activated protein kinase in hypoglycemia sensing in the ventromedial hypothalamus. Diabetes 53 1953-1958. (doi:10.2337/diabetes.53.8.1953)
110. McCrimmon RJ, Fan X, Cheng H, McNay E, Chan O, Shaw M, Ding Y, Zhu W & Sherwin RS 2006 Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counter-regulatory hormone responses in rats with defective counter-regulation. Diabetes 55 1755-1760. (doi:10.2337/db05-1359)
111. Medina-Gomez G, Yetukuri L, Velagapudi V, Campbell M, Blount M, Jimenez-Linan M, Ros M, Oresic M & Vidal-Puig A 2009 Adaptation and failure of pancreatic β cells in murine models with different degrees of metabolic syndrome. Disease Models and Mechanisms 2 582-592. (doi:10.1242/dmm.003251)
112. Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ et al. 2004 AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 569-574. (doi:10.1038/ nature02440)
113. Mitchell V, Bouret S, Beauvillain JC, Schilling A, Perret M, Kordon C & Epelbaum J 2001 Comparative distribution of mRNA encoding the growth hormone secretagogue-receptor (GHS-R) in Microcebus murinus (Primate, lemurian) and rat forebrain and pituitary. Journal of Comparative Neurology 429 469-489. (doi:10.1002/ 1096-9861(20010115)429:3 < 469::AID-CNE8 > 3.0.CO;2-#)
114. de Morentin PB & López M 2010 "Mens sana in corpore sano": exercise and hypothalamic ER stress. PLoS Biology 8 e1000464. (doi:10.1371/journal.pbio.1000464)
115. Morrison CD, Xi X, White CL, Ye J & Martin RJ 2007 Amino acids inhibit Agrp gene expression via an mTOR-dependent mechanism. American Journal of Physiology. Endocrinology and Metabolism 293 E165-E171. (doi:10.1152/ajpendo.00675.2006)
116. Murphy B, Nunes CN, Ronan JJ, Harper CM, Beall MJ, Hanaway M, Fairhurst AM, Van Der Ploeg LH, MacIntyre DE & Mellin TN 1998 Melanocortin mediated inhibition of feeding behavior in rats. Neuropeptides 32 491-497. (doi:10.1016/S0143-4179(98)90077-4)
117. Murphy BA, Fakira KA, Song Z, Beuve A & Routh VH 2009 AMP-activated protein kinase and nitric oxide regulate the glucose sensitivity of ventromedial hypothalamic glucose-inhibited neurons. American Journal of Physiology. Cell Physiology 297 C750-C758. (doi:10.1152/ajpcell.00127.2009)
118. Nahon JL, Presse F, Bittencourt JC, Sawchenko PE & Vale W 1989 The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology 125 2056-2065. (doi:10. 1210/endo-125-4-2056)
119. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K & Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409 194-198. (doi:10.1038/35051587)
120. Namkoong C, Kim MS, Jang PG, Han SM, Park HS, Koh EH, Lee WJ, Kim JY, Park IS, Park JY et al. 2005 Enhanced hypothalamic AMP-activated protein kinase activity contributes to hyperphagia in diabetic rats. Diabetes 54 63-68. (doi:10.2337/diabetes.54.1.63)
121. Nedungadi TP & Briski KP 2007 Effects of estradiol on acute and recurrent insulin-induced hypoglycemia-associated patterns of arcuate neuropeptide Y, proopiomelanocortin, and cocaine-and amphetamine-related transcript gene expression in the ovari-ectomized rat. Neuroendocrinology 86 270-276. (doi:10.1159/ 000109678)
122. Nguyen QH & Wagner EJ 2006 Estrogen differentially modulates the cannabinoid-induced presynaptic inhibition of amino acid neurotransmission in proopiomelanocortin neurons of the arcuate nucleus. Neuroendocrinology 84 123-137. (doi:10.1159/000096996)
123. Nogueiras R, Tovar S, Mitchell SE, Rayner DV, Archer ZA, Dieguez C & Williams LM 2004 Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53 2552-2558. (doi:10.2337/diabetes.53.10. 2552)
124. Nogueiras R, Wiedmer P, Perez-Tilve D, Veyrat-Durebex C, Keogh JM, Sutton GM, Pfluger PT, Castaneda TR, Neschen S, Hofmann SM et al. 2007 The central melanocortin system directly controls peripheral lipid metabolism. Journal of Clinical Investigation 117 3475-3488. (doi:10.1172/JCI31743)
125. Nogueiras R, López M, Lage R, Pérez-Tilve D, Pfluger P, Mendieta-Zeron H, Sakkou M, Wiedmer P, Benoit S, Datta R et al. 2008a Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology 149 3009-3015. (doi:10.1210/en.2007-1684)
126. Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tschop J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z et al. 2008b Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 57 2977-2991. (doi:10.2337/db08-0161)
127. Nogueiras R, Pérez-Tilve D, Veyrat-Durebex C, Morgan DA, Varela L, Haynes WG, Patterson TJ, Disse E, Pfluger P, López M et al. 2009 Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet induced obesity. Journal of Neuroscience 29 5916-5925. (doi:10.1523/JNEUROSCI.5977-08.2009)
128. Nogueiras R, López M & Diéguez C 2010 Regulation of lipid metabolism by energy availability: a role for the central nervous system. Obesity Reviews 11 185-201. (doi:10.1111/j.1467-789X.2009. 00669.x)
129. Obici S, Feng Z, Karkanias G, Baskin DG & Rossetti L 2002a Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nature Neuroscience 5 566-572. (doi:10. 1038/nn0602-861)
130. Obici S, Zhang BB, Karkanias G & Rossetti L 2002b Hypothalamic insulin signaling is required for inhibition of glucose production. Nature Medicine 8 1376-1382. (doi:10.1038/nm798)
131. Obici S, Feng Z, Arduini A, Conti R & Rossetti L 2003 Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nature Medicine 9 756-761. (doi:10. 1038/nm873)
132. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I & Barsh GS 1997 Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 135-138. (doi:10.1126/science.278.5335.135)
133. Osei-Hyiaman D, Depetrillo M, Harvey-White J, Bannon AW, Cravatt BF, Kuhar MJ, Mackie K, Palkovits M & Kunos G 2005 Cocaine-and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology 81 273-282. (doi:10.1159/000087925)
134. Oyadomari S & Mori M 2004 Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death and Differentiation 11 381-389. (doi:10.1038/sj.cdd.4401373)
135. Ozcan L, Ergin AS, Lu A, Chung J, Sarkar S, Nie D, Myers MG Jr & Ozcan U 2009 Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metabolism 9 35-51. (doi:10. 1016/j.cmet.2008.12.004)
136. Pagotto U, Marsicano G, Cota D, Lutz B & Pasquali R 2006 The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrine Reviews 27 73-100. (doi:10.1210/er.2005-0009)
137. Pecqueur C, Bui T, Gelly C, Hauchard J, Barbot C, Bouillaud F, Ricquier D, Miroux B & Thompson CB 2008 Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB Journal 22 9-18. (doi:10.1096/fj.07-8945com)
138. Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, Kangawa K, Arvat E, Ghigo E, Dieguez C & Casanueva FF 2000 Ghrelin-induced growth hormone secretion in humans. European Journal of Endocrinology 143 R11-R14. (doi:10.1530/eje.0.143R011)
139. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG & Kilduff TS 1998 Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience 18 9996-10015.
140. Plum L, Belgardt BF & Bruning JC 2006 Central insulin action in energy and glucose homeostasis. Journal of Clinical Investigation 116 1761-1766. (doi:10.1172/JCI29063)
141. Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS, Matsumoto M, Kim AJ, Cawley NX, Paik JH, Loh YP et al. 2009 The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelano-cortin neurons with regulation of food intake. Nature Medicine 15 1195-1201. (doi:10.1038/nm.2026)
142. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, Aguilar-Bryan L & Rossetti L 2005a Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434 1026-1031. (doi:10. 1038/nature03439)
143. Pocai A, Morgan K, Buettner C, Gutierrez-Juarez R, Obici S & Rossetti L 2005b Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes 54 3182-3189. (doi:10.2337/diabetes.54. 11.3182)
144. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A & Rossetti L 2006 Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. Journal of Clinical Investigation 116 1081-1091. (doi:10.1172/ JCI26640)
145. Qi J, Gong J, Zhao T, Zhao J, Lam P, Ye J, Li JZ, Wu J, Zhou HM & Li P 2008 Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitination and degradation in brown adipose tissue. EMBO Journal 27 1537-1548. (doi:10.1038/emboj.2008.92)
146. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R & Maratos-Flier E 1996 A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380 243-247. (doi:10.1038/ 380243a0)
147. Raposinho PD, White RB & Aubert ML 2003 The melanocortin agonist melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. Journal of Neuroendocrinology 15 173-181. (doi:10.1046/ j.1365-2826.2003.00962.x)
148. Ron D & Habener JF 1992 CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes and Development 6 439-453. (doi:10.1101/gad.6. 3.439)
149. Ropelle ER, Fernandes MF, Flores MB, Ueno M, Rocco S, Marin R, Cintra DE, Velloso LA, Franchini KG, Saad MJ et al. 2008a Central exercise action increases the AMPK and mTOR response to leptin. PLoS ONE 3 e3856. (doi:10.1371/journal.pone.0003856)
150. Ropelle ER, Pauli JR, Fernandes MF, Rocco SA, Marin RM, Morari J, Souza KK, Dias MM, Gomes-Marcondes MC, Gontijo JA et al. 2008b A central role for neuronal AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) in highprotein diet-induced weight loss. Diabetes 57 594-605. (doi:10. 2337/db07-0573)
151. Ropelle ER, Flores MB, Cintra DE, Rocha GZ, Pauli JR, Morari J, de Zouza CT, Moraes JC, Prada PO, Guadagnini D et al. 2010 IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKb and ER stress inhibition. PLoS Biology 8 e1000465. (doi:10.1371/journal.pbio.1000465)
152. Ruderman NB, Saha AK & Kraegen EW 2003 Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 144 5166-5171. (doi:10.1210/en.2003-0849)
153. Sakkou M, Wiedmer P, Anlag K, Hamm A, Seuntjens E, Ettwiller L, Tschop MH & Treier M 2007 A role for brain-specific homeobox factor bsx in the control of hyperphagia and locomotory behavior. Cell Metabolism 5 450-463. (doi:10.1016/j.cmet.2007.05.007)
154. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S et al. 1998 Orexins and orexin receptors: a family of hypothalamic neuro-peptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 573-585. (doi:10.1016/S0092-8674(00)80949-6)
155. Sanacora G, Kershaw M, Finkelstein JA & White JD 1990 Increased hypothalamic content of preproneuropeptide Y messenger ribo-nucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127 730-737. (doi:10.1210/endo-127-2-730)
156. Sangiao-Alvarellos S, Vázquez MJ, Varela L, Nogueiras R, Saha AK, Cordido F, López M & Diéguez C 2009 Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 150 4562-4574. (doi:10.1210/en.2009-0482)
157. Sangiao-Alvarellos S, Varela L, Vázquez MJ, Boit KD, Saha AK, Cordido F, Diéguez C & López M 2010 Influence of ghrelin and GH deficiency on AMPK and hypothalamic lipid metabolism. Journal of Neuroendocrinology 22 543-556. (doi:10.1111/j.1365-2826.2010. 01994.x)
158. Santos CX, Tanaka LY, Wosniak J & Laurindo FR 2009 Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxidants & Redox Signaling 11 2409-2427. (doi:10. 1089/ars.2009.2625)
159. Savontaus E, Conwell IM & Wardlaw SL 2002 Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Research 958 130-138. (doi:10.1016/S0006-8993(02)03674-0)
160. Schwartz MW, Marks JL, Sipols AJ, Baskin DG, Woods SC, Kahn SE & Porte D Jr 1991 Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus offood-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 128 2645-2647. (doi:10.1210/endo-128-5-2645)
161. Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP et al. 1992 Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 130 3608-3616. (doi:10.1210/en.130.6.3608)
162. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P & Baskin DG 1997 Leptin increases hypothalamic pro-opiomela-nocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46 2119-2123. (doi:10.2337/diabetes.46.12.2119)
163. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL & Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nature Medicine 2 1254-1258. (doi:10.1038/nm1196-1254)
164. Seo S, Ju S, Chung H, Lee D & Park S 2008 Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocrine Journal 55 867-874. (doi:10.1507/endocrj.K08E-091)
165. Seoane LM, López M, Tovar S, Casanueva F, Señarís R & Diéguez C 2003 Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144 544-551. (doi:10.1210/en.2002-220795)
166. Sheets AR, Fulop P, Derdak Z, Kassai A, Sabo E, Mark NM, Paragh G, Wands JR & Baffy G 2008 Uncoupling protein-2 modulates the lipid metabolic response to fasting in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology 294 G1017-G1024. (doi:10.1152/ ajpgi.00016.2008)
167. Shimizu H, Arima H, Watanabe M, Goto M, Banno R, Sato I, Ozaki N, Nagasaki H & Oiso Y 2008 Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via AMP-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 149 4544-4553. (doi:10.1210/en.2008-0229)
168. Shimizu-Albergine M, Ippolito DL & Beavo JA 2001 Downregulation of fasting-induced cAMP response element-mediated gene induction by leptin in neuropeptide Y neurons of the arcuate nucleus. Journal of Neuroscience 21 1238-1246.
169. Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD & Schwartz MW 2002 Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes 51 778-783. (doi:10.2337/diabetes. 51.3.778)
170. Sindelar DK, Ste ML, Miura GI, Palmiter RD, McMinn JE, Morton GJ & Schwartz MW 2004 Neuropeptide Y is required for hyperphagic feeding in response to neuroglucopenia. Endocrinology 145 3363-3368. (doi:10.1210/en.2003-1727)
171. Sipols AJ, Baskin DG & Schwartz MW 1995 Effect of intracerebroven-tricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 44 147-151. (doi:10.2337/ diabetes.44.2.147)
172. Smith RG 2005 Development of growth hormone secretagogues. Endocrine Reviews 26 346-360. (doi:10.1210/er.2004-0019)
173. Sorensen A, Travers MT, Vernon RG, Price NT & Barber MC 2002 Localization of messenger RNAs encoding enzymes associated with malonyl-CoA metabolism in mouse brain. Brain Research. Gene Expression Patterns 1 167-173. (doi:10.1016/ S1567-133X(02)00013-3)
174. Steinberg GR, Michell BJ, van Denderen BJ, Watt MJ, Carey AL, Fam BC, Andrikopoulos S, Proietto J, Gorgun CZ, Carling D et al. 2006a Tumor necrosis factor a-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metabolism 4 465-474. (doi:10.1016/j.cmet.2006.11.005)
175. Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA & Kemp BE 2006b Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147 3906-3914. (doi:10.1210/ en.2005-1587)
176. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A et al. 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377 530-532. (doi:10.1038/ 377530a0)
177. Stoppa GR, Cesquini M, Roman EA, Prada PO, Torsoni AS, Romanatto T, Saad MJ, Velloso LA & Torsoni MA 2008 Intracerebroventricular injection of citrate inhibits hypothalamic AMPK and modulates feeding behavior and peripheral insulin signaling. Journal of Endocrinology 198 157-168. (doi:10.1677/JOE-07-0428)
178. Sun Y, Wang P, Zheng H & Smith RG 2004 Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. PNAS 101 4679-4684. (doi:10.1073/pnas.0305930101)
179. Swart I, Jahng JW, Overton JM & Houpt TA 2002 Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 283 R1020-R1026. (doi:10.1152/ajpregu. 00501.2001)
180. Tagawa Y, Hiramatsu N, Kasai A, Hayakawa K, Okamura M, Yao J & Kitamura M 2008 Induction of apoptosis by cigarette smoke via ROS-dependent endoplasmic reticulum stress and CCAAT/ enhancer-binding protein-homologous protein (CHOP). Free Radical Biology and Medicine 45 50-59. (doi:10.1016/j.free-radbiomed.2008.03.003)
181. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A et al. 2000 Ghrelin strongly stimulates growth hormone release in humans. Journal of Clinical Endocrinology and Metabolism 85 4908-4911. (doi:10.1210/jc.85.12. 4908)
182. Tang QQ & Lane MD 2000 Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-β during adipogenesis. PNAS 97 12446-12450. (doi:10.1073/pnas.220425597)
183. Tannenbaum GS, Lapointe M, Beaudet A & Howard AD 1998 Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology 139 4420-4423. (doi:10.1210/en.139.10. 4420)
184. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schurmann A, Szanto I et al. 2006 Ghrelin action in the brain controls adipocyte metabolism. Journal of Clinical Investigation 116 1983-1993. (doi:10. 1172/JCI25811)
185. Tkacs NC & Levin BE 2004 Obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglyce-mia. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287 R1110-R1115.
186. Tkacs NC, Dunn-Meynell AA & Levin BE 2000 Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomela-nocortin mRNA in non-coma hypoglycemia. Diabetes 49 820-826. (doi:10.2337/diabetes.49.5.820)
187. Tong Q, Ye C, McCrimmon RJ, Dhillon H, Choi B, Kramer MD, Yu J, Yang Z, Christiansen LM, Lee CE et al. 2007 Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metabolism 5 383-393. (doi:10.1016/j.cmet.2007.04.001)
188. Tovar S, Nogueiras R, Tung LY, Castaneda TR, Vazquez MJ, Morris A, Williams LM, Dickson SL & Dieguez C 2005 Central administration of resistin promotes short-term satiety in rats. European Journal of Endocrinology 153 R1-R5. (doi:10.1530/eje.1.01999)
189. Trivedi P, Jiang M, Tamvakopoulos CC, Shen X, Yu H, Mock S, Fenyk-Melody J, Van Der Ploeg LH & Guan XM 2003 Exploring the site of anorectic action of peripherally administered synthetic melano-cortin peptide MT-II in rats. Brain Research 977 221-230. (doi:10. 1016/S0006-8993(03)02683-0)
190. Tschop M, Smiley DL & Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407 908-913. (doi:10.1038/35038090)
191. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R & Folwaczny C 2001a Post-prandial decrease of circulating human ghrelin levels. Journal of Endocrinological Investigation 24 RC19-RC21.
192. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E & Heiman ML. 2001b Circulating ghrelin levels are decreasedinhuman obesity. Diabetes 50 707-709. (doi:10.2337/diabetes.50.4.707)
193. Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T & Yoshimatsu H 2005 Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice. Regulatory Peptides 130 97-103. (doi:10.1016/j.regpep.2005.04.004)
194. Vázquez MJ, González CR, Varela L, Lage R, Tovar S, Sangiao-Alvarellos S, Williams LM, Vidal-Puig A, Nogueiras R, López M et al. 2008 Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion. Endocrinology 149 4534-4543. (doi:10.1210/en.2007-1708)
195. Verty AN, McFarlane JR, McGregor IS & Mallet PE 2004 Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology 145 3224-3231. (doi:10.1210/en.2004-0059)
196. Vrang N, Larsen PJ, Tang-Christensen M, Larsen LK & Kristensen P 2003 Hypothalamic cocaine-amphetamine regulated transcript (CART) is regulated by glucocorticoids. Brain Research 965 45-50. (doi:10.1016/S0006-8993(02)04064-7)
197. Wang W, Liu Y, Chen Y, Cao C, Xiang Y, Zhang D, Han L, Zhao H & Liu G 2010a Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic β-cells. Peptides 31 307-314. (doi:10.1016/j.peptides.2009.11.011)
198. Wang W, Zhang D, Zhao H, Chen Y, Liu Y, Cao C, Han L & Liu G 2010b Ghrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line. Regulatory Peptides 161 43-50. (doi:10.1016/j.regpep. 2009.12.017)
199. Watanabe M, Arima H, Fukushima K, Goto M, Shimizu H, Hayashi M, Banno R, Sato I, Ozaki N, Nagasaki H et al. 2008 Direct and indirect modulation of neuropeptide Y gene expression in response to hypoglycemia in rat arcuate nucleus. FEBS Letters 582 3632-3638. (doi:10.1016/j.febslet.2008.09.045)
200. Wen JP, Liu CE, Hu YT, Chen G & Lin LX 2010 Globular adiponectin regulates energy homeostasis through AMP-activated protein kinase-acetyl-CoA carboxylase (AMPK/ACC) pathway in the hypothalamus. Molecular and Cellular Biochemistry 344 109-115. (doi:10.1007/s11010-010-0534-2)
201. Willesen MG, Kristensen P & Romer J 1999 Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 306-316. (doi:10.1159/ 000054491)
202. Wilson BD, Bagnol D, Kaelin CB, Ollmann MM, Gantz I, Watson SJ & Barsh GS 1999 Physiological and anatomical circuitry between agouti-related protein and leptin signaling. Endocrinology 140 2387-2397. (doi:10.1210/en.140.5.2387)
203. Wolfgang MJ and Lane MD 2008 Hypothalamic malonyl-coenzymeAand the control of energy balance. Molecular Endocrinology 22 2012-2020. (doi:10.1210/me.2007-0538)
204. Wolfgang MJ, Kurama T, Dai Y, Suwa A, Asaumi M, Matsumoto S, Cha SH, Shimokawa T & Lane MD 2006 The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. PNAS 103 7282-7287. (doi:10.1073/pnas.0602205103)
205. Wolfgang MJ, Cha SH, Sidhaye A, Chohnan S, Cline G, Shulman GI & Lane MD 2007 Regulation of hypothalamic malonyl-CoA by central glucose and leptin. PNAS 104 19285-19290. (doi:10.1073/pnas. 0709778104)
206. Won JC, Jang PG, Namkoong C, Koh EH, Kim SK, Park JY, Lee KU & Kim MS 2009 Central administration of an endoplasmic reticulum stress inducer inhibits the anorexigenic effects of leptin and insulin. Obesity 17 1861-1865. (doi:10.1038/oby.2009.194)
207. Woods SC, Lotter EC, McKay LD & Porte D Jr 1979 Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282 503-505. (doi:10.1038/ 282503a0)
208. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M & Carling D 2005 Ca(2+)/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metabolism 2 21-33. (doi:10.1016/j. cmet.2005.06.005)
209. Wortley KE, Del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO & Sleeman MW 2005 Absence of ghrelin protects against early-onset obesity. Journal of Clinical Investigation 115 3573-3578. (doi:10.1172/ JCI26003)
210. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA et al. 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 4325-4328. (doi:10. 1210/en.141.11.4325)
211. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA & Bloom SR 2001a Ghrelin enhances appetite and increases food intake in humans. Journal of Clinical Endocrinology and Metabolism 86 5992. (doi:10.1210/jc.86.12.5992)
212. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal I, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA et al. 2001b Ghrelin causes hyperphagia and obesity in rats. Diabetes 50 2540-2547. (doi:10.2337/diabetes.50.11.2540)
213. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, Mann DL, Taffet GE, Baldini A, Khoury DS et al. 2006 A pivotal role for endogenous TGF-b-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. PNAS 103 17378-17383. (doi:10.1073/pnas.0604708103)
214. Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D & Kalra SP 1998 Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin. Endocrinology 139 466-473. (doi:10.1210/ en.139.2.466)
215. Yang J, Brown MS, Liang G, Grishin NV & Goldstein JL 2008 Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 387-396. (doi:10. 1016/j.cell.2008.01.017)
216. Yang CS, Lam CK, Chari M, Cheung GW, Kokorovic A, Gao S, Leclerc I, Rutter GA & Lam TK 2010 Hypothalamic AMP-activated protein kinase regulates glucose production. Diabetes 59 2435-2443. (doi:10. 2337/db10-0221)
217. Zhang X, Zhang G, Zhang H, Karin M, Bai H & Cai D 2008 Hypothalamic IKKb/NF-kB and ER stress link overnutrition to energy imbalance and obesity. Cell 135 61-73. (doi:10.1016/j.cell. 2008.07.043)
218. Zhang GG, Teng X, Liu Y, Cai Y, Zhou YB, Duan XH, Song JQ, Shi Y, Tang CS, Yin XH et al. 2009 Inhibition of endoplasm reticulum stress by ghrelin protects against ischemia/reperfusion injury in rat heart. Peptides 30 1109-1116. (doi:10.1016/j.peptides.2009.03.024)
219. Zheng H, Corkern MM, Crousillac SM, Patterson LM, Phifer CB & Berthoud HR 2002 Neurochemical phenotype of hypothalamic neurons showing Fos expression 23 h after intracranial AgRP. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 282 R1773-R1781.
220. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N et al. 2001 RoleofAMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 108 1167-1174.
221. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD. et al. 2005 Micelacking ghrelin receptors resist the development of diet-induced obesity. Journal of Clinical Investigation 115 3564-3572. (doi:10.1172/JCI26002)
222. Zigman JM, Jones JE, Lee CE, Saper CB & Elmquist JK 2006 Expression of ghrelin receptor mRNA in the rat and the mouse brain. Journal of Comparative Neurology 494 528-548. (doi:10.1002/cne.20823)
223. Ziotopoulou M, Erani DM, Hileman SM, Bjorbaek C & Mantzoros CS 2000 Unlike leptin, ciliary neurotrophic factor does not reverse the starvation-induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes 49 1890-1896. (doi:10.2337/diabetes.49.11.1890)
224. Zorrilla EP, Iwasaki S, Moss JA, Chang J, Otsuji J, Inoue K, Meijler MM & Janda KD 2006 Vaccination against weight gain. PNAS 103 13226-13231. (doi:10.1073/pnas.0605376103)